Given the resurgence of the 1st wave and how its l
Post# of 148327
(Total Views: 667)
Posted On: 06/26/2020 11:53:31 AM
Given the resurgence of the 1st wave and how its looking fiercer than before, the FDA will be under incredible pressure to approve especially after outstanding double-blind trial results, safety profile and availability of leronlimab. I am more confident than ever that FDA will give at least EUA.
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼